Kevin W. Jessing
Arrien Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Drug Transport and Resistance Mechanisms, Cholinesterase and Neurodegenerative Diseases, Microtubule and mitosis dynamics, Mercury impact and mitigation studies
Most-Cited Works
- → NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo(2003)618 cited
- → Discovery of 2-Chloro-N-(4-methoxyphenyl)-N-methylquinazolin-4-amine (EP128265, MPI-0441138) as a Potent Inducer of Apoptosis with High In Vivo Activity(2008)65 cited
- → Green-blood pigmentation in lizards(1994)35 cited
- MPC-6827, a small molecule inhibitor of microtubule formation with high brain penetration: absorption, distribution, metabolism, excretion, and clinical considerations(2005)
- → Abstract LB071: A phenomics platform combining imaging and artificial intelligence for rapid validation and advancement of novel oncology targets(2023)1 cited